Also trades as: ATX.AX (ASX) · $vol 0M
INNMF OTC
Amplia Therapeutics Limited
1W: -13.0%
1M: -11.1%
3M: -30.4%
YTD: -25.8%
1Y: -20.0%
3Y: +61.6%
5Y: -48.7%
$0.08
-0.01 (-5.88%)
Weekly Expected Move ±12.6%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$42M
+81.0% ▲
5Y CAGR: +30.7%
Total Liabilities
$2M
+3.1% ▲
5Y CAGR: +29.6%
Shareholders Equity
$40M
+88.1% ▲
5Y CAGR: +30.8%
Cash & Investments
$28M
+156.9% ▲
5Y CAGR: +72.1%
Total Debt
$342K
+2359.9% ▲
Net Debt
-$28M
-154.1% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $15M | $9M | $3M | $11M | $28M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $15M | $9M | $3M | $11M | $28M |
| Net Receivables | $2M | $1M | $3M | $4M | $5M |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $48K | $67K | $116K | $185K | $240K |
| Total Current Assets | $17M | $11M | $7M | $15M | $33M |
| Property, Plant & Equip. | $13K | $185K | $101K | $17K | $355K |
| Goodwill & Intangibles | $8M | $8M | $8M | $8M | $8M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $53K | $53K | $53K | $107K |
| Total Non-Current Assets | $8M | $8M | $8M | $8M | $8M |
| Total Assets | $24M | $19M | $15M | $23M | $42M |
| — Liabilities — | |||||
| Accounts Payable | $369K | $347K | $2M | $2M | $1M |
| Short-Term Debt | $0 | $2M | $1M | $0 | $89K |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $161K | $222K | $227K | $70K | $181K |
| Total Current Liabilities | $530K | $3M | $3M | $2M | $2M |
| Long-Term Debt | $2M | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $5K | $4K | $9K | $24K | $46K |
| Total Non-Current Liabilities | $2M | $98K | $23K | $24K | $299K |
| Total Liabilities | $3M | $3M | $3M | $2M | $2M |
| — Equity — | |||||
| Common Stock | $152M | $152M | $152M | $167M | $194M |
| Retained Earnings | -$129M | -$135M | -$139M | -$146M | -$153M |
| Accumulated OCI | -$1M | -$969K | -$1M | -$826K | -$1M |
| Total Stockholders Equity | $22M | $16M | $11M | $21M | $40M |
| Total Liabilities & Equity | $24M | $19M | $15M | $23M | $42M |
| — Key Metrics — | |||||
| Total Debt | $2M | $2M | $2M | $14K | $342K |
| Net Debt | -$13M | -$7M | -$2M | -$11M | -$28M |
| Total Investments | $0 | $0 | $0 | $0 | $0 |